Your browser doesn't support javascript.
loading
Can levetiracetam improve clinical symptoms in schizophrenic patients? A randomized placebo-controlled clinical trial.
Behdani, Fatemeh; Hassanzadeh, Behnaz; Eslamzadeh, Mahboubeh; Moradi, Marjan; Hebrani, Paria; Dadgarmoghaddam, Maliheh; Shamsaki, Negar.
Afiliación
  • Behdani F; Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences.
  • Hassanzadeh B; Department of Community Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Eslamzadeh M; Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences.
  • Moradi M; Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences.
  • Hebrani P; Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences.
  • Dadgarmoghaddam M; Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences.
  • Shamsaki N; Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences.
Int Clin Psychopharmacol ; 37(4): 159-165, 2022 07 01.
Article en En | MEDLINE | ID: mdl-35661659

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos Tipo de estudio: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Int Clin Psychopharmacol Asunto de la revista: PSICOFARMACOLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos Tipo de estudio: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Int Clin Psychopharmacol Asunto de la revista: PSICOFARMACOLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido